| Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib N Li, S Sood, S Wang, M Fang, P Wang, Z Sun, CS Yang, X Chen Clinical cancer research 11 (5), 2089-2096, 2005 | 169 | 2005 |
| Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study C Cutler, SJ Lee, S Arai, M Rotta, B Zoghi, A Lazaryan, A Ramakrishnan, ... Blood, The Journal of the American Society of Hematology 138 (22), 2278-2289, 2021 | 140 | 2021 |
| Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis X Chen, S Wang, N Wu, S Sood, P Wang, Z Jin, DG Beer, TJ Giordano, ... Clinical cancer research 10 (19), 6703-6709, 2004 | 134 | 2004 |
| Incidence and risk factors associated with a syndrome of persistent cytopenias after CAR-T cell therapy (PCTT) GR Nahas, KV Komanduri, D Pereira, M Goodman, AM Jimenez, ... Leukemia & lymphoma 61 (4), 940-943, 2020 | 86 | 2020 |
| Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in standard-of-care practice: results from the US lymphoma CAR T consortium Y Wang, P Jain, FL Locke, MJ Maurer, MJ Frank, JL Munoz, S Dahiya, ... Journal of clinical oncology 41 (14), 2594-2606, 2023 | 53 | 2023 |
| Outcomes associated with thiotepa-based conditioning in patients with primary central nervous system lymphoma after autologous hematopoietic cell transplant M Scordo, TP Wang, KW Ahn, Y Chen, S Ahmed, FT Awan, A Beitinjaneh, ... JAMA oncology 7 (7), 993-1003, 2021 | 52 | 2021 |
| Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma J Zurko, J Ramdial, M Shadman, S Ahmed, A Szabo, L Iovino, AA Tomas, ... Haematologica 108 (1), 98, 2023 | 40 | 2023 |
| Brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma: real world experience from the US Lymphoma CAR T Consortium Y Wang, P Jain, FL Locke, J Munoz, MJ Maurer, A Beitinjaneh, MJ Frank, ... Blood 138, 744, 2021 | 27 | 2021 |
| Clinical presentation and outcomes of COVID‐19 following hematopoietic cell transplantation and cellular therapy JF Camargo, MA Mendoza, R Lin, IV Moroz, AD Anderson, MI Morris, ... Transplant infectious disease 23 (4), e13625, 2021 | 22 | 2021 |
| Reduced immunogenicity of the adjuvanted recombinant zoster vaccine after hematopoietic cell transplant: a pilot study JF Camargo, RY Lin, Y Natori, AD Anderson, MC Alencar, TP Wang, ... Blood advances 4 (19), 4618-4622, 2020 | 16 | 2020 |
| Management across settings: an ambulatory and community perspective for patients undergoing CAR T-cell therapy in multiple care settings A Beaupierre Number 2/April 2019 23 (2), 27-34, 2019 | 16 | 2019 |
| An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis AM Jimenez Jimenez, M De Lima, KV Komanduri, TP Wang, MJ Zhang, ... Bone marrow transplantation 56 (12), 3068-3077, 2021 | 14 | 2021 |
| Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients M Boyiadzis, MJ Zhang, K Chen, H Abdel-Azim, MB Abid, M Aljurf, ... Leukemia 37 (5), 1006-1017, 2023 | 13* | 2023 |
| Axatilimab for chronic graft-versus-host disease after failure of at least two prior systemic therapies: results of a phase I/II study CL Kitko, M Arora, Z DeFilipp, MA Zaid, A Di Stasi, V Radojcic, CB Betts, ... Journal of Clinical Oncology 41 (10), 1864-1875, 2023 | 13 | 2023 |
| Return to work among young adult survivors of allogeneic hematopoietic cell transplantation in the United States NS Bhatt, R Brazauskas, RB Salit, K Syrjala, S Bo-Subait, H Tecca, ... Transplantation and cellular therapy 27 (8), 679. e1-679. e8, 2021 | 13 | 2021 |
| Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplant A Jimenez Jimenez, K Komanduri, S Brown, T Wang, D Pereira, ... Blood advances 6 (15), 4491-4500, 2022 | 10 | 2022 |
| Lymphoma causing gastrosplenic fistula revealed by FDG PET/CT TP Wang, M Doss, JL Tokar, S Reddy, SK Barta, QY Jian Clinical nuclear medicine 42 (11), 890-892, 2017 | 10 | 2017 |
| Subepithelial corneal immunoglobulin deposition as a manifestation of multiple myeloma: a case report and literature review TP Wang, SG Safran, JR Richter, DS Siegel, DH Vesole Clinical Lymphoma Myeloma and Leukemia 14 (1), e39-e42, 2014 | 10 | 2014 |
| Prognostic value of presalvage metabolic tumor volume in patients with relapsed/refractory diffuse large B-cell lymphoma JP Alderuccio, RA Kuker, P Barreto-Coelho, BM Martinez, F Miao, D Kwon, ... Leukemia & lymphoma 63 (1), 43-53, 2022 | 9 | 2022 |
| Persistent cytopenias after chimeric antigen receptor T-cell immunotherapy for CD19+ aggressive lymphoma: a single institution experience G Nahas, KV Komanduri, D Pereira, CL Benjamin, A Beitinjaneh, ... Biology of blood and marrow transplantation 25 (3), S180, 2019 | 9 | 2019 |
